Canada

Category

COVID-19 Vaccine Race Moves to Halifax as Canadian Volunteers Eager to Participate in CanSino Biologics Study of Ad5-nCoV

Just hours after an announcement by Justin Trudeau, Prime Minister of Canada, that the nation’s first COVID-19 vaccine clinical trial would commence soon, Canadians sent waves of unsolicited emails offering to volunteer to the Canadian Center for Vaccinology (CCfV) at...

Canada’s Center for Vaccinology Moves forward with CanSino Biologics’ Ad5-EBOV COVID-19 Vaccine Candidate

Health Canada authorized the first COVID-19 vaccine-focused clinical trial with Dalhousie University in Nova Scotia.  Now that nation’s National Research Council of Canada has entered the scene in discussion with manufacturers should the trials go well: with an eye...

Toronto’s AI-vendor Cyclica Inks Strategic Collaboration with Elite Chinese Academic Research Center targeting COVID-19

One of China’s premier government-backed, elite academic research institutions, Institute of Materia Medica, Chinese Academy of Medical Sciences, entered into a strategic research collaboration with a small Canadian-based biotech upstart called Cyclica to discovery...

DIEX Research in Quebec Drives a Multidisciplinary, Collaborative Culture to Improve Clinical Research Outcomes in Quebec

A wealthy, diverse, dynamic, multi-cultural and bilingual nation, Canada wields tremendous influence in biopharma markets given its’ position as the ninth largest biopharma drug market in the world with a relatively small population of  37.59 million people. In the...

Alberta, Canada Clinical Investigator Site ‘Central Alberta Research Clinic’ Leads LEO Pharma Delgocitinib Study for Atopic Dermatitis

Central Alberta Research Clinic conducts a Phase II eczema clinical trial for an investigational cream-based treatment called Delgocitinib (Leo Pharma). The Alberta clinical investigator site is one of three sites in Canada as well as nine in the U.S. conducting the...

Pin It on Pinterest